Delivery Order SPE2DB20D3303-SPE2DB24FA0KZ
Award Date
6/26/24
Potential Completion Date
6/27/24
Potential Value
$1.5K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,038.20 firm-fixed-price delivery order is for the supply of Qsymia 7.5 mg-46 mg capsules. The order has an ultimate completion date of August 12, 2024. Amerisourcebergen has been awarded multiple Indefinite Delivery Contracts (IDCs) by the DLA Troop Support Medical and the Department of Justice Federal...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a delivery order contract worth $4,097.22 to Amerisourcebergen Drug Corporation's Corporate Office Division. This order is for the pharmaceutical product Qsymia 7.5 mg-46 mg capsules, and has a completion date of May 7, 2024. Amerisourcebergen, as a major supplier of pharmaceuticals and medical supplies to federal agencies, holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to...
This federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of the prescription drug Qsymia 15mg-92mg in 30-count packages. The contract, valued at $2,990.04, is a delivery order with a firm fixed price and was awarded by the Defense Logistics Agency (DLA) Troop Support Medical. The contract has an ultimate completion date of July 31, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $2,608.40 firm-fixed-price delivery order is for the supply of Qsymia 7.5 mg-46 mg capsules. This award is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 with the DLA for the delivery of a comprehensive range of medical commodities to support military treatment programs and facilities...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,607.18 firm fixed-price contract is for the delivery of the prescription medication Qsymia 7.5 mg-46 mg capsules. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is the prime contractor and holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
The U.S. government awarded a Delivery Order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of the drug QSYMIA 7.5MG-46MG 30S. The contract, valued at $1,663.14, was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a unit of the Department of Defense (DoD). Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, worth up to $999,999,999.00 through December 2025, which serves as the...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which is not set aside, has a ceiling value of $1,027.48 and covers the delivery of Qsymia 7.5 mg-46 mg capsules. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,234.40, is for the delivery of the prescription medication Qsymia 3.75 mg-23 mg capsules. The contract is a firm fixed-price delivery order, with a performance period ending on May 1, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a larger...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of the medication Qsymia 3.75 mg-23 mg capsules. The award is a Delivery Order valued at $3,452.88 under an Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, which has a ceiling value of $999,999,999 and runs through November 2026. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen, as...
This federal contract award, valued at $6,070.08, was issued by the Department of Defense's Medical Supply Chain (also known as the Defense Logistics Agency Troop Support Medical) to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distribution company. The contract is for the delivery of 4564800154 QSYMIA 7.5 MG-46 MG CAPSULE 30S, a prescription medication, with a completion date of June 5, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract...